418 related articles for article (PubMed ID: 33792864)
1. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.
Alipoor B; Nikouei S; Rezaeinejad F; Malakooti-Dehkordi SN; Sabati Z; Ghasemi H
J Endocrinol Invest; 2021 Oct; 44(10):2015-2041. PubMed ID: 33792864
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases.
Bandesh K; Masih D; Bhattacharyya N; Bharadwaj D
Curr Pharm Des; 2021; 27(35):3668-3685. PubMed ID: 33719960
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in metabolic diseases: from bench to bedside.
Rey F; Zuccotti GV; Carelli S
Trends Endocrinol Metab; 2021 Oct; 32(10):747-749. PubMed ID: 34158225
[TBL] [Abstract][Full Text] [Related]
4. Role of long non-coding RNAs in metabolic control.
Ji E; Kim C; Kim W; Lee EK
Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194348. PubMed ID: 30594638
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress.
Zhang TN; Wang W; Yang N; Huang XM; Liu CF
Front Endocrinol (Lausanne); 2020; 11():457. PubMed ID: 32765426
[TBL] [Abstract][Full Text] [Related]
6. Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.
Pielok A; Marycz K
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545342
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: a valuable biomarker for metabolic syndrome.
Rashidmayvan M; Sahebi R; Ghayour-Mobarhan M
Mol Genet Genomics; 2022 Sep; 297(5):1169-1183. PubMed ID: 35854006
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease.
Rohilla S; Awasthi A; Kaur S; Puria R
Life Sci; 2021 Jan; 264():118560. PubMed ID: 33045214
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNAs in Diet-Induced Metabolic Diseases.
Brandt A; Kopp F
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891865
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.
Yang W; Lyu Y; Xiang R; Yang J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555704
[TBL] [Abstract][Full Text] [Related]
12. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
[TBL] [Abstract][Full Text] [Related]
13. A systematic analysis highlights multiple long non-coding RNAs associated with cardiometabolic disorders.
Ghanbari M; Peters MJ; de Vries PS; Boer CG; van Rooij JGJ; Lee YC; Kumar V; Uitterlinden AG; Ikram MA; Wijmenga C; Ordovas JM; Smith CE; van Meurs JBJ; Erkeland SJ; Franco OH; Dehghan A
J Hum Genet; 2018 Apr; 63(4):431-446. PubMed ID: 29382920
[TBL] [Abstract][Full Text] [Related]
14. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment.
De Vincentis A; Rahmani Z; Muley M; Vespasiani-Gentilucci U; Ruggiero S; Zamani P; Jamialahmadi T; Sahebkar A
Drug Discov Today; 2020 Jul; 25(7):1277-1286. PubMed ID: 32439605
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNAs as Diagnostic and Therapeutic Targets for Ischemic Stroke.
Wang Q; Liu X; Zhu R
Curr Pharm Des; 2019; 25(10):1115-1121. PubMed ID: 30919772
[TBL] [Abstract][Full Text] [Related]
18. Identifying potential functional lncRNAs in metabolic syndrome by constructing a lncRNA-miRNA-mRNA network.
Yao D; Lin Z; Zhan X; Zhan X
J Hum Genet; 2020 Nov; 65(11):927-938. PubMed ID: 32690864
[TBL] [Abstract][Full Text] [Related]
19. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases.
Zacharopoulou E; Gazouli M; Tzouvala M; Vezakis A; Karamanolis G
Dig Liver Dis; 2017 Oct; 49(10):1067-1072. PubMed ID: 28869157
[TBL] [Abstract][Full Text] [Related]
20. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
